BlackRock Fund Advisors increased its position in Adeptus Health Inc. (NYSE:ADPT) by 19.3% during the third quarter, Holdings Channel reports. The firm owned 1,077,645 shares of the company’s stock after buying an additional 174,156 shares during the period. BlackRock Fund Advisors owned 6.59% of Adeptus Health worth $46,393,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of ADPT. Macquarie Group Ltd. boosted its position in Adeptus Health by 112.3% in the second quarter. Macquarie Group Ltd. now owns 100,032 shares of the company’s stock valued at $5,168,000 after buying an additional 52,911 shares during the period. Eagle Asset Management Inc. boosted its position in Adeptus Health by 7.5% in the third quarter. Eagle Asset Management Inc. now owns 679,615 shares of the company’s stock valued at $29,257,000 after buying an additional 47,438 shares during the period. Peregrine Capital Management LLC acquired a new position in Adeptus Health during the third quarter valued at $16,164,000. Bank of New York Mellon Corp boosted its position in Adeptus Health by 98.7% in the third quarter. Bank of New York Mellon Corp now owns 2,100,041 shares of the company’s stock valued at $90,406,000 after buying an additional 1,043,115 shares during the period. Finally, Northpointe Capital LLC acquired a new position in Adeptus Health during the third quarter valued at $14,602,000.
Shares of Adeptus Health Inc. (NYSE:ADPT) traded down 1.554% during midday trading on Friday, reaching $7.728. The company had a trading volume of 363,784 shares. Adeptus Health Inc. has a 12-month low of $7.55 and a 12-month high of $73.44. The stock’s 50 day moving average is $8.15 and its 200-day moving average is $28.17. The stock has a market capitalization of $126.70 million, a PE ratio of 1.370 and a beta of 0.37.
Several equities analysts have recently weighed in on the company. Jefferies Group LLC reiterated a “buy” rating and set a $77.00 price objective on shares of Adeptus Health in a report on Monday, October 24th. Stephens cut Adeptus Health from an “overweight” rating to an “equal weight” rating in a report on Wednesday, November 2nd. Bank of America Corp cut Adeptus Health from a “buy” rating to an “underperform” rating in a report on Wednesday, November 2nd. Goldman Sachs Group, Inc. (The) cut Adeptus Health from a “buy” rating to a “neutral” rating and cut their price objective for the company from $72.00 to $12.00 in a report on Friday, November 4th. Finally, KeyCorp set a $31.00 price objective on Adeptus Health and gave the company a “buy” rating in a report on Wednesday, November 2nd. Three analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $44.80.
About Adeptus Health
Adeptus Health Inc is a patient-centered healthcare company. The Company is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Company has approximately 80 freestanding facilities and over two licensed general hospitals.
Want to see what other hedge funds are holding ADPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adeptus Health Inc. (NYSE:ADPT).